Selective inhibition of eukaryotic translation initiation factor 2α dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis

被引:263
作者
Cnop, Miriam
Ladriere, Laurence
Hekerman, Paul
Ortis, Fernanda
Cardozo, Alessandra K.
Dogusan, Zeynep
Flamez, Daisy
Boyce, Michael
Yuan, Junying
Eizirik, Decio L.
机构
[1] Free Univ Brussels, Erasmus Sch Med, Expt Med Lab, B-1070 Brussels, Belgium
[2] Erasme Univ Hosp, Div Endocrinol, B-1070 Brussels, Belgium
[3] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M607627200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Free fatty acids cause pancreatic beta-cell apoptosis and may contribute to beta-cell loss in type 2 diabetes via the induction of endoplasmic reticulum stress. Reductions in eukaryotic translation initiation factor (eIF) 2 alpha phosphorylation trigger P-cell failure and diabetes. Salubrinal selectively inhibits eIF2 alpha dephosphorylation, protects other cells against endoplasmic reticulum stress-mediated apoptosis, and has been proposed as a beta-cell protector. Unexpectedly, salubrinal induced apoptosis in primary beta-cells, and it potentiated the deleterious effects of oleate and palmitate. Salubrinal induced a marked eIF2 alpha phosphorylation and potentiated the inhibitory effects of free fatty acids on protein synthesis and insulin release. The synergistic activation of the PERK-eIF2 alpha branch of the endoplasmic reticulum stress response, but not of the IRE1 and activating transcription factor-6 pathways, led to a marked induction of activating transcription factor-4 and the pro-apoptotic transcription factor CHOP. Our findings demonstrate that excessive eIF2 alpha phosphorylation is poorly tolerated by beta-cells and exacerbates free fatty acid-induced apoptosis. This modifies the present paradigm regarding the beneficial role of eIF2 alpha phosphorylation in beta-cells and must be taken into consideration when designing therapies to protect beta-cells in type 2 diabetes.
引用
收藏
页码:3989 / 3997
页数:9
相关论文
共 58 条
  • [21] Protection of Bcl-2 by salubrinal
    Kessel, David
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 346 (04) : 1320 - 1323
  • [22] BCL-6:: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells
    Kharroubi, I.
    Lee, C. -H
    Hekerman, P.
    Darville, M. I.
    Evans, R. M.
    Eizirik, D. L.
    Cnop, M.
    [J]. DIABETOLOGIA, 2006, 49 (10) : 2350 - 2358
  • [23] Free fatty acids and Cytokines induce pancreatic β-cell apoptosis by different mechanisms:: Role of nuclear factor-κB and endoplasmic reticulum stress
    Kharroubi, I
    Ladrière, L
    Cardozo, AK
    Dogusan, Z
    Cnop, M
    Eizirik, DL
    [J]. ENDOCRINOLOGY, 2004, 145 (11) : 5087 - 5096
  • [24] Cloning, expression, and cellular localization of the oncogenic 58-kDa inhibitor of the RNA-activated human and mouse protein kinase
    Korth, MJ
    Lyons, CN
    Wambach, M
    Katze, MG
    [J]. GENE, 1996, 170 (02) : 181 - 188
  • [25] Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic β-cells
    Kutlu, B
    Darville, MI
    Cardozo, AK
    Eizirik, DL
    [J]. DIABETES, 2003, 52 (02) : 348 - 355
  • [26] Pancreatic β-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK
    Ladiges, WC
    Knoblaugh, SE
    Morton, JF
    Korth, MJ
    Sopher, BL
    Baskin, CR
    MacAuley, A
    Goodman, AG
    LeBoeuf, RC
    Katze, MG
    [J]. DIABETES, 2005, 54 (04) : 1074 - 1081
  • [27] MULTIPLE EFFECTS OF LEUCINE ON GLUCAGON, INSULIN, AND SOMATOSTATIN SECRETION FROM THE PERFUSED RAT PANCREAS
    LECLERCQMEYER, V
    MARCHAND, J
    WOUSSENCOLLE, MC
    GIROIX, MH
    MALAISSE, WJ
    [J]. ENDOCRINOLOGY, 1985, 116 (03) : 1168 - 1174
  • [28] PURIFICATION AND PARTIAL CHARACTERIZATION OF A CELLULAR INHIBITOR OF THE INTERFERON-INDUCED PROTEIN-KINASE OF MR 68,000 FROM INFLUENZA VIRUS-INFECTED CELLS
    LEE, TG
    TOMITA, J
    HOVANESSIAN, AG
    KATZE, MG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) : 6208 - 6212
  • [29] LING Z, 1994, DIABETOLOGIA, V37, P15
  • [30] Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2
    Lu, PD
    Jousse, C
    Marciniak, SJ
    Zhang, YH
    Novoa, I
    Scheuner, D
    Kaufman, RJ
    Ron, D
    Harding, HP
    [J]. EMBO JOURNAL, 2004, 23 (01) : 169 - 179